Friday, January 22, 2016 4:02:12 PM
Like the chart on this opportunity...took a starter postion.
http://finance.yahoo.com/news/weekly-ceo-buys-highlights-final-155715591.html
Opko Health Inc.: CEO, Chairman and 10% owner Phillip Frost, MD et al bought 20,000 shares
Opko Health (OPK) CEO, Chairman and 10% owner Phillip Frost, MD et al bought 20,000 shares on Dec. 30, 2015, at an average price of $10.05 per share. Opko Health was originally incorporated in Delaware in October 1991 under the name Cytoclonal Pharmaceutics Inc. Opko Health has a market cap of $5.48 billion; its shares were traded at around $10.05 with a P/S ratio of 20.10. Opko Health had an annual average earnings growth of 9.50% over the past 10 years.
Opko Health recently reported its third quarter 2015 financial results. Consolidated revenues increased to $143.0 million from $19.8 million for the three months ended Sept. 30, 2015 compared to three months ended Sept. 30, 2014, and increased to $215.5 million from $65.6 million for the nine months ended Sept. 30, 2015 as compared to the 2014 period.
Investor 100
Recent OPK News
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
